AYTU BIOPHARMA, INC Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
AYTU BIOPHARMA, INC (AYTU) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $100.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-09-22
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $100.00K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $100.00K 10-K · filed 2026-09-22 |
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $100.00K 10-Q · filed 2026-02-03 |
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $100.00K 10-K · filed 2026-09-22 |
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-14 |
| 2024-06-30 | $200.00K 10-K · filed 2025-09-23 |
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-14 |
| 2023-03-31 | $200.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $200.00K 10-Q · filed 2023-02-21 |
| 2022-09-30 | $100.00K 10-Q/A · filed 2023-02-21 |
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $300.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $601.00K 10-Q · filed 2020-11-12 |
| 2018-09-30 | $2.86M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $161.00K 10-K · filed 2018-09-06 |
| 2018-03-31 | $260.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |